Summary
The progression of subclinical polyneuropathy over 2.5 years has been studied in a representative group of 75 young patients with Type 1 (insulin-dependent) diabetes (initial age 16–19 years). The relationships between changes in nerve function, glycaemic control and concurrently developing microvascular complications (retinopathy, microproteinuria) were investigated. Deterioration of motor, sensory and autonomic nerve function, retinopathy and microproteinuria was related to poor glycaemic control. In addition, there was an association between developing neural and microvascular complications which was not diminished when their common relationship to hyperglycaemia was taken into account. These findings suggest that, although poor glycaemic control is an essential permissive factor in the early development of diabetic polyneuropathy, other influences, shared with microvascular complications, must also be important.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Pirart J (1978) Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1: 168–88
Clarke BE, Ewing DJ, Campbell IW (1979) Diabetic autonomic neuropathy. Diabetologia 17: 195–212
Editorial (1983) Diabetic neuropathy — where are we now? Lancet 1: 1366–7
Ewing DJ, Campbell IW, Clarke BF (1980) The natural history of diabetic autonomic neuropathy. Quart J Med 49: 95–108
Winegrad AI, Simmons DA, Martin DB (1983) Has one diabetic complication been explained? N Engl J Med 308: 152–4
Brown MJ, Asbury AK (1984) Diabetic neuropathy. Annals Neurology 15: 2–12
Clements RS Jr, Bell D (1982) Diagnostic, pathogenetic and therapeutic aspects of diabetic neuropathy. Spec Top Endocrinol Metab 3: 1–43
Young RJ, Ewing DJ, Clarke BF (1983) Nerve function and metabolic control in teenage diabetics. Diabetes 32: 142–7
Young RJ, Ewing DJ, Clarke BF (1983) A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful neuropathy. Diabetes 32: 938–42
Tibi L, Young RJ, Smith AF (1982) Clinical implications of labile HbA1 as assayed by the electrophoretic method. Clin Chim Acta 126: 257–63
Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285: 916–8
Viberti G, Keen H (1984) The pattern of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy. Diabetes 33: 686–92
Holman RR, Dornan TL, Mayon-White V, Howard-Williams J, Orde-Pecker C, Jenkins L, et al (1983) Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. Lancet 1: 204–8
Hillson RM, Hockaday TDR, Newton DJ (1984) Hyperglycaemia is one correlate of deterioration in vibration sense during the 5 years after diagnosis of Type 2 (non-insulin-dependent) diabetes. Diabetologia 26: 122–6
Gregersen G (1968) Variations in motor nerve conduction velocity produced by changes of the metabolic state in diabetic patients. Diabetologia 4: 273–7
Ward JD, Barnes CG, Fisher DJ, Jessop JD, Baker RWP (1971) Improvement in nerve function following treatment in newly diagnosed diabetes. Lancet 1: 428–31
Fraser DM, Campbell IW, Ewing DJ, Murray A, Neilson JMM, Clarke BF (1977) Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus. Diabetes 26: 546–50
Peterson CM, Jones RL, Dupuis A, Levine BS, Bernstein R, O'Shea M (1979) Feasibility of improved blood glucose control in patients with insulin dependent diabetes mellitus. Diabetes Care 2: 329–35
Pietri A, Ehle AL, Raskin P (1980) Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes 29: 668–71
Boulton AJM, Drury J, Clarke B, Ward JD (1982) Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 5: 386–91
Graf RJ, Halter JB, Halar E, Porte D Jr (1979) Nerve conduction abnormalities in untreated maturity onset diabetes: relation to levels of fasting plasma and glycosylated hemoglobin. Ann Intern Med 90: 198–303
Graf RJ, Halter JB, Pfeifer MA, Halar E, Brozovich F, Porte D Jr (1981) Glycaemic control and nerve conduction abnormalities in non-insulin dependent diabetic subjects. Ann Intern Med 94: 307–11
Young RJ, Zhou YQ, Rodriguez E, Prescott RJ, Ewing DJ, Clarke BF (1986) Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes (in press)
Palmberg P, Smith M, Waltman S, Krupin T, Singer P, Burgess D, Wendlant T, Achtenberg J, Cryer P, Santiago J, White N, Kilo C, Daughaday W (1981) The natural history of retinopathy in insulin dependent juvenile-onset diabetes. Ophthalmology 88: 613–8
Siperstein MD (1983) Diabetic microangiopathy and the control of blood glucose. N Engl J Med 309: 1577–9
Knowler WC, Bennet PH, Ballantine GJ (1980) Increased incidence of retinopathy in diabetics with elevated blood pressure. N Engl J Med 302: 645–50
Young RJ, McCulloch DK, Prescott RJ, Clarke BF (1984) Alcohol — another risk factor for diabetic retinopathy? Br Med J 288: 1035–7
Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T, Steno Study Group (1983) Effect of 1 year of near normal blood glucose levels on retinopathy in insulin dependent diabetics. Lancet 1: 200–4
Kroc collaborative study group (1984) Blood glucose control and the evolution of diabetic retinopathy and albuminuria: a preliminary multicentre trial. N Engl J Med 311: 35–72
Dahl-Jogensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O (1985) Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J 290: 811–5
Viberti GC, Hill RD, Jarrett RJ, Argypopoulos A, Mammud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1: 1430–32
Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin dependent patients. N Engl J Med 311: 89–93
Mathieson ER, Oxenbull B, Johansen K, Svendsen PA, Deckert T (1984) Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 26: 406–10
Wiseman M, Viberti G, Mackintosh D, Jarrett RJ, Keen H (1984) Glycaemic, arterial pressure and microalbuminuria in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 26: 401–5
Williams E, Timperley WR, Ward JD, Duckworth T (1980) Electron microscopical studies of vessels in diabetic periheral neuropathy. J Clin Pathol 33: 462–70
Parving HH, Viberti GC, Christiansen JS, Lassen NA (1983) Haemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 32: 943–9
Clarke BF, Young RJ, Maryn CN, Ewing DJ (1984) Aldose reductase inhibitors in diabetes: Sorbinil. Diabetic Medicine 1: 88–90
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Young, R.J., Macintyre, C.C.A., Martyn, C.N. et al. Progression of subclinical polyneuropathy in young patients with Type 1 (insulin-dependent) diabetes: associations with glycaemic control and microangiopathy (microvascular complications). Diabetologia 29, 156–161 (1986). https://doi.org/10.1007/BF02427086
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02427086